Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Necrotizing enterocolitis; and common findings: Recurrent Staphylococcus aureus infections. 5 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 2 | Recurrent lower respiratory tract infections, Recurrent Staphylococcus aureus infections |
FCN3 encodes ficolin 3 (299 aa). Calcium-dependent lectin, which acts as a pattern recognition receptor that initiates the lectin pathway of the complement system, a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system. Highest expression in Lung (1,136 TPM) and Liver (65.8 TPM).
Immunodeficiency due to ficolin3 deficiency is associated with mutations in the FCN3 gene on chromosome 1.
The FCN3 protein participates in Lectin pathway of complement activation pathway.
FCN3 is classified as a druggable target (Druggable Genome, External Side Of Plasma Membrane, and Fibrinogen categories) with score 0.0.
Genetic testing for FCN3 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 1 always present feature, 1 common feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for immunodeficiency due to ficolin3 deficiency.
4 publications have been identified in PubMed for immunodeficiency due to ficolin3 deficiency. Research spans Epidemiology / Natural History (50%), Other (25%), and Review / Meta-Analysis (25%).
García-Soidán A (2025). [PMID: 40513623](https://pubmed.ncbi.nlm.nih.gov/40513623/). *J Allergy Clin Immunol*. [Other]
Parker Z (2025). [PMID: 40340734](https://pubmed.ncbi.nlm.nih.gov/40340734/). *BMC Res Notes*. [Epidemiology / Natural History]
Yilmaz Tekinhatun H (2025). [PMID: 41071379](https://pubmed.ncbi.nlm.nih.gov/41071379/). *Immunol Res*. [Epidemiology / Natural History]
McMurray JC (2024). [PMID: 39294906](https://pubmed.ncbi.nlm.nih.gov/39294906/). *Allergy Asthma Proc*. [Review / Meta-Analysis]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 4:33 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Lungs and breathing
1 |
Recurrent lower respiratory tract infections |
Age of onset: newborn period.